NEWS
F&P Healthcare sees revenue dropping to $1.67-$1.7b

AUCKLAND: Fisher & Paykel Healthcare’s share price fell sharply after the respiratory products maker said… read more
Rapid testing company Ellume’s big biotech IPO still on table

SYDNEY: There’s at least one $600 million-plus biotech still testing the IPO waters in 2022…. read more